San Diego, CA, United States of America

Jon E Chatterton


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2010-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jon E Chatterton: Innovator in Excitatory Glycine Receptors

Introduction

Jon E Chatterton is a notable inventor based in San Diego, CA. He has made significant contributions to the field of neuroscience through his innovative work on excitatory glycine receptors. With a total of 2 patents, Chatterton's inventions have the potential to impact diagnostic and therapeutic methods in medical science.

Latest Patents

Chatterton's latest patents focus on excitatory glycine receptors and methods. The inventions provide isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Additionally, the patents include excitatory glycine receptors containing either NR3B or NR3A polypeptides. Methods for detecting excitatory glycine receptor ligands, agonists, and antagonists are also provided, along with related diagnostic and therapeutic methods.

Career Highlights

Throughout his career, Jon E Chatterton has worked with esteemed institutions such as the Sanford Burnham Medical Research Institute and Yale University. His experience in these organizations has allowed him to collaborate with leading experts in the field.

Collaborations

Chatterton has had the opportunity to work alongside notable colleagues, including Stuart A Lipton and Dongxian Zhang. These collaborations have further enriched his research and contributions to the field.

Conclusion

Jon E Chatterton's innovative work on excitatory glycine receptors showcases his dedication to advancing medical science. His patents and collaborations highlight his significant role in the field of neuroscience.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…